Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Aggressive prostate cancer linked to hereditary breast cancer, confirms study

Aggressive prostate cancer, one of the leading causes of cancer deaths in men, is associated with BRCA2 mutations, which are also linked to hereditary breast cancer, ovarian cancer and pancreas cancer, among others.

10 Jan 2019

Northwestern Medicine receives $10 million gift to create new institute for urologic cancers

Northwestern Medicine received a $10 million gift to fund the creation of a new multidisciplinary institute dedicated to urologic cancers.

7 Jan 2019

Study finds increase in suicide risk after cancer diagnosis

New research indicates that the risk of suicide increases significantly in the first year following a diagnosis of cancer, and this increase varies by the type of cancer diagnosed.

7 Jan 2019

Traditional and new imaging methods used for prostate cancer diagnosis

Prostate cancer is the second prevent type of cancer that exists. Prostate cancer is usually a slowly progressing disease but it can sometimes manifest as an aggressive cancer. Prostate imaging is the primary way to diagnose the disease and this necessity drives its demand in the clinic.

24 Dec 2018

Scientists discover two therapies that slow progression of pediatric leukemia in mice

Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years in the journal Cell, and the final paper published Dec. 20 in Genes & Development.

24 Dec 2018

CWRU researcher receives nearly $1 million to study drug resistance mechanisms in prostate cancer

Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 over three years to investigate drug resistance mechanisms in prostate cancer.

24 Dec 2018

Interval of time to biochemical failure could be used as surrogate endpoint for prostate cancer

An analysis of the NRG Oncology clinical trial NRG-RTOG 9202 showed that the interval of time to biochemical failure, or the time it takes for previously treated cancer to return as indicated by prostate specific antigen rise, could be used as a surrogate endpoint for locally advanced prostate cancer.

21 Dec 2018

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Black men diagnosed with prostate cancer classified as low risk may actually have a more-aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests.

18 Dec 2018

New computer model helps predict course of the disease in prostate cancer patients

How does a normal cell turn into a deadly cancer? Seeking an answer to this question, and working alongside other international working groups, researchers from Charité - Universitätsmedizin Berlin examined the tumor genomes of nearly 300 prostate cancer patients.

14 Dec 2018

Prostate cancer detection using MRI now first-line investigation tool

Men with prostate cancers under the NHS would soon get non-invasive MRI scans for detections after a health body (National Institute for Health and Care Excellence or NICE) has given its approval. At present the MRI scans for detection have undergone pilot trials in three areas only and may soon be available all over Wales.

13 Dec 2018

Surgical treatment unnecessary for many prostate cancer patients

Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian men with prostate cancer for 29 years. The results are now published in The New England Journal of Medicine.

12 Dec 2018

Faster, cheaper test has potential to enhance prostate cancer evaluation

For men newly diagnosed with prostate cancer or patients previously treated, the risk of metastasis is a crucial determinant of whether to choose conservative management or undergo further treatment.

12 Dec 2018

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

New research on prostate cancer staging shows that PSMA-targeted PET/MRI performs equally as well as currently used predictive tools to determine the risk for advanced disease.

12 Dec 2018

New computer model predicts prostate cancer progression

An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the course of disease for prostate cancer.

11 Dec 2018

Men with inflammatory bowel disease have higher prostate cancer risk

Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year study from Northwestern Medicine.

7 Dec 2018

New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

7 Dec 2018

Optimization of drug dose sizes can reduce pharmaceutical wastage

Pharmaceuticals are often dosed according to patient weight or body size which means that a dose must be individually measured. In a new study, lead author Anthony Hatswell of Delta Hat Limited and University College London in the UK, shows that by optimizing drug dose sizes available, wastage can be cut by as much as 50 percent.

6 Dec 2018

New study confirms effectiveness of PSA screening in reducing prostate cancer deaths

A new study has confirmed the effectiveness of Prostate-specific Antigen screening in reducing prostate cancer mortality.

5 Dec 2018

Cancer cells could be detected irrespective of site and type using simple test

Australian researchers have found that cells containing cancer could soon be detected using a simple test. The test could one day change how cancers are diagnosed, the team says. The results of the study to develop the test were published in the journal Nature Communications.

4 Dec 2018

Cancer DNA signature will revolutionize point-of-care diagnostics

Researchers have developed a potentially game-changing new technology that could revolutionize cancer point-of-care (POC) diagnostics.

4 Dec 2018

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Aggressive prostate cancer linked to hereditary breast cancer, confirms study

Northwestern Medicine receives $10 million gift to create new institute for urologic cancers

Study finds increase in suicide risk after cancer diagnosis

Traditional and new imaging methods used for prostate cancer diagnosis

Scientists discover two therapies that slow progression of pediatric leukemia in mice

CWRU researcher receives nearly $1 million to study drug resistance mechanisms in prostate cancer

Interval of time to biochemical failure could be used as surrogate endpoint for prostate cancer

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

New computer model helps predict course of the disease in prostate cancer patients

Prostate cancer detection using MRI now first-line investigation tool

Surgical treatment unnecessary for many prostate cancer patients

Faster, cheaper test has potential to enhance prostate cancer evaluation

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

New computer model predicts prostate cancer progression

Men with inflammatory bowel disease have higher prostate cancer risk

New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies

Optimization of drug dose sizes can reduce pharmaceutical wastage

New study confirms effectiveness of PSA screening in reducing prostate cancer deaths

Cancer cells could be detected irrespective of site and type using simple test

Cancer DNA signature will revolutionize point-of-care diagnostics

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in